CMS certification 110038
Archbold Memorial Hospital
915 Gordon Avenue & Mimosa Drive, Thomasville, GA 31792
Archbold Memorial Hospital has a CMS overall rating of 2 out of 5 stars. 64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 23 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. Emergency patients spend a median of 3 h 53 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 413 completed surveys, 15% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as medium; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | GA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 451 visits sampled · US median for EDs of the same volume: 2 h 45 min | 3 h 53 min | 2 h 42 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 15 visits sampled | 5 h 44 min | 5 h 8 min | 4 h 17 min |
| Left before being seen Lower is better · 30,555 patients | 1% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 385 patients | 58% | 63% | 65% |
How Archbold Memorial Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Archbold Memorial HospitalThis hospital | 2/5 | 64% | 3 h 53 min | 2 better 1 worse |
| Tift Regional Medical CenterSame ZIP area · Tifton | 3/5 | 65% | 4 h 15 min | 1 better 2 worse |
| Colquitt Regional Medical CenterSame ZIP area · Moultrie | 4/5 | 78% | 2 h 53 min | 2 better 2 worse |
| Dorminy Medical CenterSame ZIP area · Fitzgerald | Not rated | 57% | 2 h 37 min | 1 better |
| Archbold MitchellSame ZIP area · Camilla | Not rated | 70% | 1 h 49 min | No different |
| Phoebe Sumter Medical CenterSame ZIP area · Americus | 3/5 | 68% | 3 h 36 min | 1 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,906 cases | Too few cases | 4.2% | 3.9% |
| Heart attack 136 cases | Too few cases | 9.9% | 11.9% |
| Heart failure 213 cases | Too few cases | 12% | 11.1% |
| Pneumonia 234 cases | Too few cases | 15.8% | 15.2% |
| Stroke 154 cases | Too few cases | 11.2% | 11.9% |
| COPD 55 cases | Too few cases | 9.3% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.05 likely 0.7 – 1.41 | 1 |
| Deaths after a serious but treatable surgical complication 32 cases | No different | 215.17 per 1,000 likely 159.75 per 1,000 – 270.59 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 2,714 cases | No different | 1.04 per 1,000 likely 0.23 per 1,000 – 1.84 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 2,917 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.39 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 2,963 cases | No different | 0.28 per 1,000 likely 0.08 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 747 cases | No different | 3.62 per 1,000 likely 2.03 per 1,000 – 5.2 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 320 cases | No different | 1.54 per 1,000 likely 0 per 1,000 – 3.2 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 298 cases | No different | 4.68 per 1,000 likely 0 per 1,000 – 11.87 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 749 cases | No different | 3.87 per 1,000 likely 1.55 per 1,000 – 6.18 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 306 cases | No different | 6.35 per 1,000 likely 2.52 per 1,000 – 10.18 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 174 cases | No different | 1.67 per 1,000 likely 0.18 per 1,000 – 3.16 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 569 cases | No different | 0.92 per 1,000 likely 0 per 1,000 – 1.95 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.68 likely 0.22 – 1.65 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.6 likely 0.19 – 1.46 | 1 |
| Surgical site infections after colon surgery | No different | 1.81 likely 0.66 – 4.01 | 1 |
| MRSA bloodstream infections | No different | 0.59 likely 0.1 – 1.95 | 1 |
| C. diff intestinal infections | Better | 0.26 likely 0.11 – 0.54 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 233 cases | Too few cases | 14.6% | 14.4% |
| Readmitted after heart failure 564 cases | Too few cases | 19.5% | 21.3% |
| Readmitted after pneumonia 389 cases | Too few cases | 17.9% | 17.3% |
| Readmitted after COPD 154 cases | Too few cases | 21.3% | 20% |
| Days back in hospital after a heart attack 119 cases | Too few cases | -25.5 days per 100 | — |
| Days back in hospital after heart failure 224 cases | Too few cases | 6.1 days per 100 | — |
| Days back in hospital after pneumonia 238 cases | Too few cases | 16.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 923 cases | No different | 12.9 per 1,000 likely 9.9 per 1,000 – 17 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 119 cases | No different | 9.5 per 100 likely 6.9 per 100 – 13 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 119 cases | No different | 5.2 per 100 likely 3.5 per 100 – 7.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 324 cases | No different | 0.8 likely 0.6 – 1 | — |
3 more measures had too few cases here to report.
Clinicians registered at this address
84 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 22 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 10 |
| Internal Medicine | 9 |
| Diagnostic Radiology | 8 |
| Dietitian, Registered | 7 |
| Emergency Medicine | 7 |
| Family | 6 |
| Anesthesiologist Assistant | 5 |
| Anesthesiology | 5 |
| Pharmacist | 5 |
| Nurse Practitioner | 3 |
| Speech-Language Pathologist | 3 |
| Family Medicine | 2 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2024 $557,422
- 2025 $755,052
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $94,824 | 9 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $301,643 | 3 |
| Novartis Pharmaceuticals Corporation | $216,727 | 2 |
| CathWorks, Inc. | $114,013 | 8 |
| AngioDynamics, Inc. | $75,667 | 3 |
| AstraZeneca UK Limited | $19,679 | 1 |
| Stryker Corporation | $16,037 | 4 |
| E.R. Squibb & Sons, L.L.C. | $6,083 | 2 |
| Becton, Dickinson and Company | $3,120 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study Novartis Pharmaceuticals Corporation | $216,727 |
| A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not… Merck Sharp & Dohme LLC | $134,443 |
| ALL-RISE CathWorks, Inc. | $114,013 |
| An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician s Choice in … Merck Sharp & Dohme LLC | $100,617 |
| A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Trea… Merck Sharp & Dohme LLC | $66,583 |
| CAMBRIA-2 A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Est… AstraZeneca UK Limited | $19,679 |
| A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab, or with Standard of Care Chemotherapy, versus Standard of Care Chemoth… E.R. Squibb & Sons, L.L.C. | $4,208 |
| Connect MM: The Multiple Myeloma Disease Registry. The purpose of the Connect MM Registry is to explore the natural history and real world management… E.R. Squibb & Sons, L.L.C. | $1,875 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Archbold Memorial Hospital
Is Archbold Memorial Hospital a good hospital?
Archbold Memorial Hospital has a CMS overall rating of 2 out of 5 stars. Of the 23 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Archbold Memorial Hospital?
64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 413 completed HCAHPS surveys.
How long is the wait in the Archbold Memorial Hospital emergency room?
Emergency patients spend a median of 3 h 53 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with medium patient volume, like this one, the median is 2 h 45 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Archbold Memorial Hospital receive money from drug and device companies?
Drug and device makers reported $755,052 in payments to Archbold Memorial Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.